Literature DB >> 18288400

Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line.

Yueling Jin1, Xiaoqiang Tian, Yanfang Shang, Peiling Huang.   

Abstract

DLC-1 (deleted in liver cancer-1) is a potential tumor suppressor gene, which is inactive in liver carcinogenesis. To observe the effects of DLC-1 gene expression on cell proliferation and migration in the human colon cancer cell line, RNAi Lipo-recombinant of the DLC-1 gene (pGCsil-DLC-1) was constructed and transduced into LoVo cells which are positive for DLC-1 gene expression. Results showed that the RNAi recombinant effectively inhibited the expression of the DLC-1 gene in LoVo cells. Additionally, our data showed decreased DLC-1 gene expression which resulted in the promotion of LoVo cell proliferation. Flow cytometry in cell cycle detection further indicated that the DLC-1 gene induced cell cycle arrest at G2/M and a cell migration assay confirmed that the knocking down of DLC-1 gene expression promotes LoVo cell migration. Our observations suggest that the DLC-1 gene is associated with LoVo cell proliferation, migration and cell cycle distribution. DLC-1 is a potential suppressor gene in the colon cancer LoVo cell line and may play an important role in colon cancer mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288400

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells.

Authors:  Yi-Ping Shih; Yoshikazu Takada; Su Hao Lo
Journal:  Mol Cancer Res       Date:  2011-11-07       Impact factor: 5.852

2.  DLC1 as a regulator of proliferation, invasion, cell cycle, and apoptosis in cutaneous squamous cell carcinoma.

Authors:  Cailing Yang; Dapeng Wu; Jinling Jia; Dong Liu; Zhanguo Li; Chunxiao Zhang; Min Li; Yonghua Xia
Journal:  Tumour Biol       Date:  2013-04-28

3.  DLC-1 as a modulator of proliferation, apoptosis and migration in Burkitt's lymphoma cells.

Authors:  Minhua Feng; Bo Huang; Zunguo Du; Xiaoping Xu; Zi Chen
Journal:  Mol Biol Rep       Date:  2010-10-01       Impact factor: 2.316

4.  Mutation of the nm23-H1 gene has a non-dominant role in colorectal adenocarcinoma.

Authors:  Yueling Jin; Zhensheng Dai
Journal:  Mol Clin Oncol       Date:  2016-05-09

5.  Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells.

Authors:  Tai Young Kim; In Sook Kim; Hyun Soon Jong; Jung Weon Lee; Tae You Kim; Mira Jung; Yung Jue Bang
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

6.  p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities.

Authors:  X-Y Yang; M Guan; D Vigil; C J Der; D R Lowy; N C Popescu
Journal:  Oncogene       Date:  2009-01-19       Impact factor: 9.867

7.  SH3 domain regulation of RhoGAP activity: Crosstalk between p120RasGAP and DLC1 RhoGAP.

Authors:  Jocelyn E Chau; Kimberly J Vish; Titus J Boggon; Amy L Stiegler
Journal:  Nat Commun       Date:  2022-08-15       Impact factor: 17.694

8.  Downregulation of DLC-1 gene by promoter methylation during primary colorectal cancer progression.

Authors:  Haixia Peng; Feng Long; Zhiyuan Wu; Yimin Chu; Ji Li; Rong Kuai; Jing Zhang; Zhihua Kang; Xinju Zhang; Ming Guan
Journal:  Biomed Res Int       Date:  2012-12-23       Impact factor: 3.411

9.  Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.

Authors:  Yuqi Su; Li Lin; Jingwen Zhang; Yaqi Jiang; Changqie Pan; Li Sun; Jiangman Duan; Wangjun Liao
Journal:  Mol Med Rep       Date:  2015-08-03       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.